Skip to main content
Year archive

Medy-Tox Inc. — 2021 filings

All 48 regulatory filings released by Medy-Tox Inc. (086900) in 2021, sourced directly from the official regulator.

48 Filings
2021 Period
2021 filings (48)
Filing Released Lang
배당락(주식배당)
Notice of Dividend Amount
2021-12-28 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2021-12-14 Korean
주식배당결정
Notice of Dividend Amount
2021-12-01 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
자기주식취득결과보고서
Transaction in Own Shares
2021-11-15 Korean
주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2021-10-21 Korean
[기재정정]주요사항보고서(자기주식취득결정)
Transaction in Own Shares
2021-10-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-09-14 Korean
투자판단관련주요경영사항(애브비(AbbVie Inc.), 개선된 신경독소후보 제품(MT10109L) 권리반환 및 계약종료)
M&A Activity
2021-09-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-08-23 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-08-13 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-08-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-07-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-06 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-06-25 Korean
기타경영사항(자율공시)(미국 국제무역위원회(US International Trade Commission, ITC)의 2020년 12월16일 최종 판결에 따른 AEON Biopharma Inc.와 Medytox Inc. 의 라이선스 합의 계약 체결)
Legal Proceedings Report
2021-06-22 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-04-28 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2021-04-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2021-04-20 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2021-04-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-05 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-23 Korean
사업보고서 (2020.12)
Audit Report / Information FY 2020
2021-03-23 Korean
[기재정정]신규시설투자등
Capital/Financing Update
2021-03-22 Korean
주주총회소집공고
AGM Information
2021-03-16 Korean
[기재정정]주주총회소집공고
AGM Information
2021-03-16 Korean
주주총회소집결의
AGM Information
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-02-26 Korean
투자판단관련주요경영사항(EVOLUS, INC., Allergan, Inc, Medytox Inc 간 3자 합의 계약의 건)
Legal Proceedings Report
2021-02-22 Korean
타법인주식및출자증권취득결정
M&A Activity
2021-02-22 Korean
투자판단관련주요경영사항(이노톡스주 행정처분 및 회수 폐기명령)
Legal Proceedings Report
2021-01-18 Korean